Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds
The anti-HIV drug lopinavir-ritonavir does not improve survival of patients with covid-19 in hospital, according to new findings from the UK RECOVERY trial.Announcing the results, which are yet to be…
